All News #Library
Biotech
Immunitas Presents IMT-380 Preclinical Data at FASEB
30 Jul 2025 //
PR NEWSWIRE
Immunitas to Present Preclinical Data Supporting Combination of IMT-009
05 Mar 2024 //
PR NEWSWIRE
Immunitas Announces First Patient Dosed in Phase 1/2a Study of IMT-009
04 Jan 2023 //
PR NEWSWIRE
Lonza and Immunitas Therapeutics Announce Manufacturing Agreement
15 Apr 2021 //
PRESS RELEASE

Market Place
Sourcing Support